BD Alaris 8015 PC Unit (5.7″ Display) – Recertified

Quick answer: The BD Alaris 8015 PC Unit with the 5.7-inch display is the controller of the Alaris modular infusion system. It runs up to four infusion and monitoring modules through one color interface and Guardrails Suite MX. Units on this page run PCU software earlier than v12.3, and the installed version varies by unit, so confirm the version your facility requires before ordering. IPR Medical sells recertified 8015 units backed by IPR Medical’s warranty, repairs them in-house, and stocks replacement parts.

Looking for v12.3? This listing covers earlier Alaris-generation 8015 PC Units. IPR Medical also sells the BD Alaris 8015 PC Unit (v12.3 Software), built on BD Alaris-generation hardware with parts BD lists as not interchangeable with older PCUs. If your fleet has moved to v12.3, start there.

Overview

The BD Alaris 8015 PC Unit is the central controller — the “brain” — of the Alaris modular infusion system. It doesn’t infuse on its own. What it does is provide a unified color interface, a shared Guardrails drug library, and a single point of programming and alarm management for up to four simultaneously attached infusion and monitoring modules. That modularity is the core of the Alaris system’s appeal: one PCU can run a large-volume pump, a syringe pump, a PCA module, and an EtCO2 module (or, on PCU software earlier than v12.1.2, an SpO2 module) at the same time, all through the same display, all governed by the same facility-defined drug library. The 5.7″ display variant offers a larger screen footprint than the 4.7″ model — useful for high-acuity environments where quick visual confirmation of multiple running parameters matters. Installed software version varies by unit — see the module compatibility and cybersecurity notes below before ordering.

Guardrails Suite MX and Drug Library

The Alaris 8015 runs Guardrails Suite MX — BD’s comprehensive medication error prevention software — which supports up to 30 patient-specific care area profiles. Each profile carries its own Drug Library, IV Fluid library, channel labels, and instrument configuration settings appropriate to the care area. Drug entries can carry Hard Limits that cannot be overridden during programming, and Soft Limits that can be overridden with clinical confirmation — giving pharmacy teams precise control over how aggressively the system enforces dosing boundaries across different patient populations. Optional Clinical Advisories provide visual on-screen guidance at the drug level. Data Sets are built using the Guardrails Editor software by a facility’s own clinical team, transferred to the pump fleet via the Alaris Systems Manager wireless infrastructure, and activated by clinical staff. CQI event data from every infusion alert is stored on-board and accessible via Guardrails CQI Reporter for continuous safety improvement analysis.

Modular Architecture and Compatible Modules

The Alaris 8015 PCU accepts up to four infusion or monitoring modules attached to either side of the unit or daisy-chained from one another. Modules are identified by position (A, B, C, D) from left to right, and adding or removing a module while the system is powered on does not interrupt active infusions on other channels — the system reidentifies module positions automatically. Compatible modules include the Alaris Pump Module 8100 (large-volume), Syringe Module 8110, PCA Module 8120, SpO2 Modules 8210 and 8220, and the EtCO2 Module 8300. The Auto-ID Module 8600 can be added as a recognized fifth module, combining Guardrails dose limit technology with barcode scanning for IV solution auto-selection and patient ID verification. Only one PCA module and one SpO2 module can be connected at a time. Module compatibility depends on the PCU software version: BD removed Alaris SpO2 Module (8210/8220) compatibility beginning with PCU software v12.1.2, so SpO2 monitoring requires a PCU on earlier software. Confirm module compatibility for your PCU software version before ordering.

Wireless Connectivity and Fleet Management

The Alaris 8015 connects through a CompactFlash wireless network card installed behind the PCU’s rear panel; depending on the card, units support 802.11b/g, 802.11a/b/g, or 802.11a/b/g/n, and some units are non-wireless. When connected to wireless infrastructure, the PCU integrates with Alaris Systems Manager, which enables bi-directional data exchange — pushing updated Data Sets to the fleet and pulling pump event and CQI logs for centralized review. If wireless communication is interrupted, the system operates normally in manual mode without loss of infusion function. The wireless network indicator on the PCU illuminates when connected and blinks during active data transfer. For facilities evaluating wireless upgrades across an Alaris fleet, BD lists RF card and cover/panel kits for Alaris PCUs (including an 802.11a/b/g/n kit for PCUs on v9.13, v9.19, v9.33, or v12), so the wireless standard can often be upgraded without replacing the PCU. Confirm card and software compatibility with IPR Medical before ordering.

Battery and Power

The Alaris 8015 PCU is powered by a 12V, 4000 mAh Nickel-Metal Hydride (NiMH) battery that charges whenever the unit is connected to AC power, regardless of whether the pump is on or off. Battery runtime varies significantly with the number and type of modules attached. With a single pump module infusing at 25 ml/h, a new, fully charged battery will run approximately 6 hours. Four pump modules at 25 ml/h reduces that to approximately 3 hours. Syringe and PCA configurations at 5 ml/h deliver similar runtimes — 6 hours for a single module, 3 hours for four. SpO2 monitoring runs approximately 4.5 hours; EtCO2 approximately 4 hours. Battery life expectancy is approximately 2 years under normal use and maintenance. The battery charges on the PCU itself — no separate charging station is required.

FDA Device Corrections and Safety Bulletins

The BD Alaris System — including the 8015 PC Unit — has been subject to multiple FDA recalls and device corrections since 2020. Facilities operating Alaris 8015 PCUs should verify current software versions and review active recall status with their biomedical engineering and pharmacy teams. IPR Medical recommends contacting BD directly to determine remediation status and scheduling for any affected units.

1. Class I Voluntary Recall (February 2020) — Software Anomalies: BD initiated a voluntary recall affecting approximately 774,000 Alaris System devices in the U.S. after identifying multiple software problems: inaccurate system error codes that could cause medication interruption or pump shutdown; interference with the delay start programming function; low battery alarm failures that could result in unannounced power loss mid-infusion; KVO alarm misprioritization; and customer concentration programming inaccuracies that could produce dosing errors. The FDA reported 55 injuries and 1 death associated with this recall at the time of classification. BD directed facilities to follow mitigation steps outlined in customer communications and announced plans for a software update to remediate the issues.

2. Additional Class I Recalls (June–August 2020) — Hardware and Software: BD issued additional voluntary recalls in mid-2020 covering hardware issues that could result in pump malfunction, along with further software-related corrections. Several of these were designated Class I by the FDA.

3. Remediation and 510(k) Clearance (2021–2023): BD filed a 510(k) submission in April 2021 covering software version 12.1.2 and various hardware updates. Remediation of affected fleet units began in July 2021. The FDA granted 510(k) clearance for the updated BD Alaris System in July 2023, covering updated PCU hardware, new software with cybersecurity enhancements, and interoperability improvements across pump, syringe, PCA, monitoring, and Auto-ID modules. BD committed to remediating or replacing all current U.S. market Alaris devices with the 510(k)-cleared version.

4. Cybersecurity Bulletins (2020–2023): BD voluntarily disclosed several cybersecurity vulnerabilities affecting the Alaris 8015 PCU across multiple bulletins. Notable disclosures include: a wireless credential exposure vulnerability on PCUs running software v9.5 or earlier (requires physical disassembly to exploit); a network session denial-of-service vulnerability (CVE-2020-25165) affecting wireless capability, patched in software v12.1.1 and later; and eight additional CVEs disclosed in 2023 affecting versions 12.1.3 and earlier, including configuration authentication gaps and IUI bus encryption limitations (CISA advisory ICSMA-23-194-01). In October 2023, BD released BD Alaris System v12.3, updated the PCU to software version 12.3.1, and recommended that customers update to v12.3 where available based on regulatory authorization. BD notes that three PCU vulnerabilities (CVE-2023-30559, CVE-2023-30560, and CVE-2023-30561) remain present in PCU v12.3.1 and recommends compensating controls, such as placing Alaris PCUs on their own network segment. The FDA’s Global Unique Device Identification Database (GUDID) also lists a BD Alaris PCU Model 8015 with software v12.4.0 in commercial distribution. For the 2023 vulnerabilities, BD reported no known exploitation in any customer environment or clinical setting and assessed its control measures as reducing the probability of harm to improbable.

5. Class 2 Correction (February 2026, Z-1645-2026) — Wi-Fi TLS Labeling: BD’s labeling did not state which Transport Layer Security (TLS) versions must be enabled on the hospital network for secure Wi-Fi communication with Alaris and BD Alaris PCUs under enterprise-level security. Health Canada’s notice for the same issue lists PCU software v12.1.3 and earlier. If TLS 1.0 is disabled, PCUs may fail to connect and a memory leak can lead to a System Error. BD instructs users to watch the PCU’s wireless indicator, follow wireless-downtime protocols if it is not lit, power-cycle the PCU and reprogram any active infusion after a System Error, and have IT confirm which TLS versions must remain enabled.

6. Class I Infusion Set Recall (2025–2026) — BD Alaris Pump Infusion Sets: Starting in July 2025, BD notified customers that some compatible infusion sets may perform outside user-manual ranges for flow rate and bolus accuracy, occlusion time to alarm, and post-occlusion bolus volume when used with the BD Alaris Pump Module 8100, most notably at low rates. The FDA classified the action as Class I and, as of its October 2026 update, lists Guardrails Suite MX software up to v12.6. On August 19, 2026, BD directed customers to discard the sets on its discontinued list and to prioritize alternate sets for critical-care, neonatal, infant, and pediatric areas; BD’s mitigations also include keeping the fluid container no more than 21 inches above the top of the pump module.

7. Class 2 Correction (August 2024, Z-3138-2024) — IUI Connectors: BD identified an increase in bent contacts on the new female (left) IUI connectors, which can prevent a module from operating and delay the start of an infusion or monitoring. The FDA records list specific serial numbers for the PCU 8015 and for the pump, syringe, PCA, and EtCO2 modules. BD instructs users to inspect all IUI connectors before use and to send any device with a bent or lifted pin to biomedical engineering or qualified service personnel.

8. Class 1 Labeling Correction (September 2023, Z-0184-2024) — Syringe Compatibility: The compatible-syringe lists for the Alaris Syringe and PCA Modules included syringes that had not been validated, and the FDA record lists the BD Alaris PCU (REF 8015). Facilities were told to stop using Cardinal Health Monoject syringes with the Alaris Syringe and PCA Modules, except SKU 8881135609, and to replace their compatibility lists.

Action recommended: Facilities operating BD Alaris 8015 PCUs should verify the installed software version on each unit, confirm remediation status with BD, and follow BD’s current recommendation to update to BD Alaris System v12.3 or later where available. PCUs running software v12.1.3 or earlier are within the scope of CISA advisory ICSMA-23-194-01. If your network uses enterprise-level Wi-Fi security, confirm which TLS versions your PCUs require (see item 5). IPR Medical can assist with parts and service — call 855-477-8866 or email cs@iprmed.com.

Because FDA device corrections and safety communications may be updated or expanded after the date of this listing, IPR Medical recommends that facilities also check the FDA’s official resources directly to ensure they have the most current information:

• FDA Medical Device Recalls Database
• FDA Medical Device Safety
• FDA MedWatch
• CISA Advisory ICSMA-23-194-01 — BD Alaris System
• BD Cybersecurity Bulletin — BD Alaris System with Guardrails Suite MX

IPR Medical — Your Source for the BD Alaris 8015

IPR Medical buys, sells, repairs, and stocks parts for the BD Alaris 8015 PC Unit. Whether you need a recertified unit, a replacement component, or service support for an existing Alaris fleet, our team is equipped to help.

IPR Medical buys, sells, repairs, and stocks parts for the BD Alaris 8015 PC Unit. Contact us at 855-477-8866 or cs@iprmed.com.

Frequently asked questions

Do you sell the Alaris 8015 with v12.3 software?
Yes. See the BD Alaris 8015 PC Unit (v12.3 Software). It is built on newer BD Alaris-generation hardware, runs PCU software v12.3, and does not support SpO2 modules. Units on this page run earlier software, which varies by unit.

Why choose the 5.7-inch display Alaris 8015?
The 5.7-inch screen is larger and easier to read than the 4.7-inch model, which helps in high-acuity areas where clinicians need quick visual confirmation of several running parameters. Both versions run Guardrails Suite MX with the same clinical workflow, so staff who know either one will recognize it. Units on this page run PCU software earlier than v12.3, and the installed version varies by unit, so confirm the version your facility requires before ordering either size. If you need v12.3, see the BD Alaris 8015 PC Unit (v12.3 Software).

How long does the Alaris 8015 battery last?
The 12V, 4000 mAh NiMH battery charges whenever the unit is on AC power. With one pump module at 25 ml/h, a new battery runs about 6 hours; with four modules, about 3 hours. SpO2 monitoring runs about 4.5 hours and EtCO2 about 4 hours. Expected battery life is about 2 years.

Which software version addresses the 2023 Alaris cybersecurity advisory?
CISA advisory ICSMA-23-194-01 covers BD Alaris PCU Model 8015 software v12.1.3 and earlier. BD recommends updating to BD Alaris System v12.3 or later where available based on regulatory authorization; that release updated the PCU to v12.3.1. BD notes that three PCU vulnerabilities remain in v12.3.1 and recommends compensating controls such as network segmentation. Units on this page run software earlier than v12.3, so contact IPR Medical to confirm the software version of any unit before you order, or see the BD Alaris 8015 PC Unit (v12.3 Software) if you need v12.3.

Can IPR Medical help with our Guardrails data set?
Questions about Guardrails Suite MX data sets, drug libraries, or Alaris Systems Manager should go directly to our team. Call IPR Medical at (855) 477-8866 or email cs@iprmed.com, Monday through Friday, 7:00 AM to 4:30 PM Pacific, and we will talk through your Alaris fleet.

Can IPR Medical repair our Alaris PC Units?
Yes. IPR Medical repairs BD Alaris PC Units in-house. U.S. customers can request a free inbound FedEx or UPS shipping label through our RMA form, receive a free evaluation within 1 to 2 business days, and approve a written estimate before work begins. Repaired units are tested to OEM specifications, cleaned, and carry a 90-day warranty.

Repair service: IPR Medical also repairs BD Alaris pumps in house, with a free shipping label, a free evaluation and a 90-day repair warranty. See BD Alaris pump repair.

Trademark Notice: BD, and all other brand names, model names, and part numbers shown are trademarks of their respective owners and are used on this page only to identify the original manufacturer’s equipment offered here, consistent with nominative fair use. This listing is offered by IPR Medical, an ISO 9001:2015-certified independent service organization, and is not sponsored by, affiliated with, or endorsed by BD.